204 related articles for article (PubMed ID: 7717972)
1. The apolipoprotein B3304-3317 peptide as an inhibitor of the lipoprotein (a):apolipoprotein B-containing lipoprotein interaction.
Trieu VN; Olsson U; McConathy WJ
Biochem J; 1995 Apr; 307 ( Pt 1)(Pt 1):17-22. PubMed ID: 7717972
[TBL] [Abstract][Full Text] [Related]
2. Interaction of apolipoprotein(a) with apolipoprotein B-containing lipoproteins.
Trieu VN; Zioncheck TF; Lawn RM; McConathy WJ
J Biol Chem; 1991 Mar; 266(9):5480-5. PubMed ID: 1848551
[TBL] [Abstract][Full Text] [Related]
3. Bacterial expression and characterization of human recombinant apolipoprotein(a) kringle IV type 9.
Chung FZ; Wu LH; Lee HT; Mueller WT; Spahr MA; Eaton SR; Tian Y; Settimi PD; Oxender DL; Ramharack R
Protein Expr Purif; 1998 Jul; 13(2):222-8. PubMed ID: 9675066
[TBL] [Abstract][Full Text] [Related]
4. Sequences within apolipoprotein(a) kringle IV types 6-8 bind directly to low-density lipoprotein and mediate noncovalent association of apolipoprotein(a) with apolipoprotein B-100.
Gabel BR; Koschinsky ML
Biochemistry; 1998 May; 37(21):7892-8. PubMed ID: 9601051
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the mechanism of lipoprotein(a) assembly.
Koschinsky ML; Marcovina SM; May LF; Gabel BR
Clin Genet; 1997 Nov; 52(5):338-46. PubMed ID: 9520124
[TBL] [Abstract][Full Text] [Related]
6. Interaction of apolipoprotein[a] with apolipoproteinB-100 Cys3734 region in lipoprotein[a] is confirmed immunochemically.
Guevara J; Valentinova NV; Garcia O; Gotto AM; Yang CY; Legal S; Gaubatz J; Sparrow JT
J Protein Chem; 1996 Jan; 15(1):17-25. PubMed ID: 8838586
[TBL] [Abstract][Full Text] [Related]
7. Proposed mechanisms for binding of apo[a] kringle type 9 to apo B-100 in human lipoprotein[a].
Guevara J; Spurlino J; Jan AY; Yang CY; Tulinsky A; Prasad BV; Gaubatz JW; Morrisett JD
Biophys J; 1993 Mar; 64(3):686-700. PubMed ID: 8386013
[TBL] [Abstract][Full Text] [Related]
8. Identification of a critical lysine residue in apolipoprotein B-100 that mediates noncovalent interaction with apolipoprotein(a).
Becker L; McLeod RS; Marcovina SM; Yao Z; Koschinsky ML
J Biol Chem; 2001 Sep; 276(39):36155-62. PubMed ID: 11473115
[TBL] [Abstract][Full Text] [Related]
9. Expression of apolipoprotein(a) kringle IV type 9 in Escherichia coli: demonstration of a specific interaction between kringle IV type 9 and apolipoproteinB-100.
Rahman M; Jia Z; Gabel BR; Marcovina SM; Koschinsky ML
Protein Eng; 1998 Dec; 11(12):1249-56. PubMed ID: 9930675
[TBL] [Abstract][Full Text] [Related]
10. The binding of animal low-density lipoproteins to human apolipoprotein(a).
Trieu VN; McConathy WJ
Biochem J; 1995 Aug; 309 ( Pt 3)(Pt 3):899-904. PubMed ID: 7639708
[TBL] [Abstract][Full Text] [Related]
11. A synthetic peptide that inhibits lipoprotein(a) assembly.
Sharp RJ; Perugini MA; Marcovina SM; McCormick SP
Arterioscler Thromb Vasc Biol; 2003 Mar; 23(3):502-7. PubMed ID: 12615683
[TBL] [Abstract][Full Text] [Related]
12. Identification of the cysteine residue in apolipoprotein(a) that mediates extracellular coupling with apolipoprotein B-100.
Koschinsky ML; Côté GP; Gabel B; van der Hoek YY
J Biol Chem; 1993 Sep; 268(26):19819-25. PubMed ID: 8366120
[TBL] [Abstract][Full Text] [Related]
13. Identification of two functionally distinct lysine-binding sites in kringle 37 and in kringles 32-36 of human apolipoprotein(a).
Ernst A; Helmhold M; Brunner C; Pethö-Schramm A; Armstrong VW; Müller HJ
J Biol Chem; 1995 Mar; 270(11):6227-34. PubMed ID: 7890760
[TBL] [Abstract][Full Text] [Related]
14. Identification of sequences in apolipoprotein(a) that maintain its closed conformation: a novel role for apo(a) isoform size in determining the efficiency of covalent Lp(a) formation.
Becker L; Cook PM; Koschinsky ML
Biochemistry; 2004 Aug; 43(31):9978-88. PubMed ID: 15287725
[TBL] [Abstract][Full Text] [Related]
15. Quantitative evaluation of the contribution of weak lysine-binding sites present within apolipoprotein(a) kringle IV types 6-8 to lipoprotein(a) assembly.
Becker L; Cook PM; Wright TG; Koschinsky ML
J Biol Chem; 2004 Jan; 279(4):2679-88. PubMed ID: 14581473
[TBL] [Abstract][Full Text] [Related]
16. Polymorphonuclear cells isolated from human peripheral blood cleave lipoprotein(a) and apolipoprotein(a) at multiple interkringle sites via the enzyme elastase. Generation of mini-Lp(a) particles and apo(a) fragments.
Edelstein C; Italia JA; Scanu AM
J Biol Chem; 1997 Apr; 272(17):11079-87. PubMed ID: 9111002
[TBL] [Abstract][Full Text] [Related]
17. Interactions of low density lipoprotein2 and other apolipoprotein B-containing lipoproteins with lipoprotein(a).
Ye SQ; Trieu VN; Stiers DL; McConathy WJ
J Biol Chem; 1988 May; 263(13):6337-43. PubMed ID: 2966154
[TBL] [Abstract][Full Text] [Related]
18. Mutation of lysine residues in apolipoprotein B-100 causes defective lipoprotein[a] formation.
Liu CY; Broadhurst R; Marcovina SM; McCormick SP
J Lipid Res; 2004 Jan; 45(1):63-70. PubMed ID: 13130121
[TBL] [Abstract][Full Text] [Related]
19. Evidence that the fibrinogen binding domain of Apo(a) is outside the lysine binding site of kringle IV-10: a study involving naturally occurring lysine binding defective lipoprotein(a) phenotypes.
Klezovitch O; Edelstein C; Scanu AM
J Clin Invest; 1996 Jul; 98(1):185-91. PubMed ID: 8690792
[TBL] [Abstract][Full Text] [Related]
20. Apo(a) and ApoB Interact Noncovalently Within Hepatocytes: Implications for Regulation of Lp(a) Levels by Modulation of ApoB Secretion.
Youssef A; Clark JR; Marcovina SM; Boffa MB; Koschinsky ML
Arterioscler Thromb Vasc Biol; 2022 Mar; 42(3):289-304. PubMed ID: 35045727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
